GE Healthcare has completed the acquisition of the assets of Orbotech Medical Solutions Ltd (OMS), a subsidiary of Orbotech Ltd (Orbotech). OMS manufactures cadmium zinc telluride (CZT) detectors used in GE Healthcare’s Alcyone nuclear medicine technology.
GE Healthcare’s Alcyone technology combines CZT detectors, focused pin-hole collimation, 3-D reconstruction, and stationary data acquisition to reduce acquisition time and dose. Alcyone technology enables views of cardiac anatomy and functionality with greater clarity and speed, resulting in short scan times, and up to a four-fold reduction in dose.
The FDA recently cleared the use of CZT technology in assessment and early detection of breast cancer in women who are at high risk for the disease. The Discovery NM750b molecular breast imaging system utilizes a small field of view CZT gamma camera dedicated to breast imaging.